Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition
Masato Nagino, Itaru Endo(Yokohama City University), Akio Yanagisawa(Kyoto first Red Cross hospital), Takashi Mizuno(Nagoya University), Hiroaki Shimizu(Chiba University), Ryota Higuchi(Tokyo Women's Medical University), Katsuhiko Uesaka(Shizuoka Cancer Center), Hideyuki Yoshitomi(Chiba University), Toshifumi Wakai(Niigata University Medical and Dental Hospital), Hiroyuki Maguchi(Teine Keijinkai Hospital), Toshio Tsuyuguchi(Chiba University), Keiji Sano(Teikyo University), Yoshiki Hirooka(Fujita Health University), Yukihiro Yokoyama(Nagoya University), Junji Furuse(Kyorin University), Kojiro Suzuki(Aichi Medical University), Tomoki Ebata(Nagoya University Hospital), Takuji Okusaka(National Cancer Center), Masaru Konishi(Shizuoka Cancer Center), Michiaki Unno(Tohoku University), Satoshi Hirano(Hokkaido University), Kazuaki Shimada(Tokyo National Hospital), Masahiro Yoshida(International University of Health and Welfare), Hiroshi Kijima(Hirosaki University), Hideya Yamazaki(Kyoto Prefectural University of Medicine), Hiroyuki Isayama(Juntendo University), Taku Aoki(Dokkyo Medical University)
Cited by 235
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k